Literature DB >> 23729935

Alterations in circulating T-cell lymphocyte populations in children with obstructive sleep apnea.

Hui-Leng Tan1, David Gozal, Yang Wang, Hari P R Bandla, Rakesh Bhattacharjee, Richa Kulkarni, Leila Kheirandish-Gozal.   

Abstract

STUDY
OBJECTIVES: Changes in lymphocyte phenotype and functionality have been described in adult patients with obstructive sleep apnea (OSA). We hypothesized that OSA is associated with T lymphocyte alterations in children, particularly in T regulatory lymphocytes (T regs), and aimed to characterize circulating T lymphocyte subsets in children with OSA.
DESIGN: Cross-sectional.
SETTING: Kosair Children's Hospital (Louisville, KY, USA) and Comer Children's Hospital (Chicago, IL, USA). PARTICIPANTS: Consecutively recruited children being evaluated for habitual snoring.
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: Overnight polysomnography (PSG) was performed and a fasting blood sample was obtained from the patients. Flow cytometry was performed on peripheral blood mononuclear cells stained for CD3, CD4, CD8, CD25, FOXP3, interleukin-4 (IL-4), interferon-γ (IFN-γ), and IL-17. Patients were divided into three groups based on their PSG: controls (apnea-hypopnea indices [AHI] < 1/h total sleep time [TST]), mild OSA (1 ≤ AHI < 5/hTST), moderate-severe OSA (AHI ≥ 5/h TST). The percentage of CD4+ and T reg lymphocytes differed across groups. Children with moderate-severe OSA had significantly reduced T reg than control children (median [interquartile range] 4.8 [3.8-5.7% CD4+] versus 7.8 [7.0-9.2% CD4+]; P < 0.001). There were also significant differences in the percentage of T helper 1 (Th1) lymphocytes and in Th1:Th2 ratios between groups. Children with moderate-severe OSA had increased Th1 cells (P = 0.001) and Th1:Th2 ratios (P = 0.0026) compared with children with mild OSA and control children. Associations between AHI and T reg (P = 0.0003; r = -0.46), CD4+ lymphocytes (P = 0.0047; r = -0.37), and Th1:Th2 ratios (P = 0.0009; r = 0.43) emerged. In addition, the percentage of T reg was inversely correlated with Th1:Th2 ratios (P = 0.029; r = -0.29).
CONCLUSIONS: Pediatric OSA is associated with reduced T reg population and altered Th1:Th2 balance toward Th1 predominance, suggesting a shift to a proinflammatory state. The changes in lymphocytic phenotypes associated with OSA may contribute to the variance in systemic inflammation and downstream morbidities associated with this condition.

Entities:  

Keywords:  T cell lymphocytes; children; inflammation; sleep apnea

Mesh:

Year:  2013        PMID: 23729935      PMCID: PMC3648675          DOI: 10.5665/sleep.2724

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  69 in total

1.  Blood pressure in children with obstructive sleep apnea.

Authors:  C L Marcus; M G Greene; J L Carroll
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

2.  Differential effects of regulatory T cells on the initiation and regression of atherosclerosis.

Authors:  A C Foks; V Frodermann; M ter Borg; K L L Habets; I Bot; Y Zhao; M van Eck; Th J C van Berkel; J Kuiper; G H M van Puijvelde
Journal:  Atherosclerosis       Date:  2011-05-05       Impact factor: 5.162

3.  Sleep-disordered breathing and school performance in children.

Authors:  D Gozal
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

4.  Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment.

Authors:  Elena Maganto-García; De-Xiu Bu; Margarite L Tarrio; Pilar Alcaide; Gail Newton; Gabriel K Griffin; Kevin J Croce; Francis W Luscinskas; Andrew H Lichtman; Nir Grabie
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

5.  Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity.

Authors:  Carol L Rosen; Emma K Larkin; H Lester Kirchner; Judith L Emancipator; Sarah F Bivins; Susan A Surovec; Richard J Martin; Susan Redline
Journal:  J Pediatr       Date:  2003-04       Impact factor: 4.406

6.  Systemic inflammation in non-obese children with obstructive sleep apnea.

Authors:  David Gozal; Laura D Serpero; Oscar Sans Capdevila; Leila Kheirandish-Gozal
Journal:  Sleep Med       Date:  2007-09-06       Impact factor: 3.492

7.  Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis.

Authors:  T van Es; G H M van Puijvelde; A C Foks; K L L Habets; I Bot; E Gilboa; T J C Van Berkel; J Kuiper
Journal:  Atherosclerosis       Date:  2009-08-31       Impact factor: 5.162

Review 8.  Sleep, sleep disorders and inflammation in children.

Authors:  David Gozal
Journal:  Sleep Med       Date:  2009-07-31       Impact factor: 3.492

9.  Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma.

Authors:  Dominik Hartl; Barbara Koller; Alexander T Mehlhorn; Dietrich Reinhardt; Thomas Nicolai; Dolores J Schendel; Matthias Griese; Susanne Krauss-Etschmann
Journal:  J Allergy Clin Immunol       Date:  2007-04-06       Impact factor: 10.793

10.  Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing.

Authors:  Riva Tauman; Louise M O'Brien; David Gozal
Journal:  Sleep Breath       Date:  2007-06       Impact factor: 2.655

View more
  19 in total

1.  CD4(+)T-lymphocyte subsets in nonobese children with obstructive sleep apnea syndrome.

Authors:  Jin Ye; Hui Liu; Peng Li; Zhuang-gui Chen; Ge-hua Zhang; Qin-tai Yang; Yuan Li
Journal:  Pediatr Res       Date:  2015-04-10       Impact factor: 3.756

2.  Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea.

Authors:  A Carreras; S X Zhang; E Peris; Z Qiao; Y Wang; I Almendros; D Gozal
Journal:  Int J Obes (Lond)       Date:  2014-10-09       Impact factor: 5.095

3.  Risk of obstructive sleep apnea in African American patients with chronic rhinosinusitis.

Authors:  Jessica W Hui; Jason Ong; James J Herdegen; Hajwa Kim; Christopher D Codispoti; Vahid Kalantari; Mary C Tobin; Robert P Schleimer; Pete S Batra; Phillip S LoSavio; Mahboobeh Mahdavinia
Journal:  Ann Allergy Asthma Immunol       Date:  2017-04-27       Impact factor: 6.347

4.  Whole Genome DNA Methylation Analysis of Obstructive Sleep Apnea: IL1R2, NPR2, AR, SP140 Methylation and Clinical Phenotype.

Authors:  Yung-Che Chen; Ting-Wen Chen; Mao-Chang Su; Chung-Jen Chen; Kuang-Den Chen; Chia-Wei Liou; Petrus Tang; Ting-Ya Wang; Jen-Chieh Chang; Chin-Chou Wang; Hsin-Ching Lin; Chien-Hung Chin; Kuo-Tung Huang; Meng-Chih Lin; Chang-Chun Hsiao
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

Review 5.  Genotype-phenotype interactions in pediatric obstructive sleep apnea.

Authors:  Leila Kheirandish-Gozal; David Gozal
Journal:  Respir Physiol Neurobiol       Date:  2013-04-03       Impact factor: 1.931

Review 6.  Sleep Disordered Breathing in Children.

Authors:  Christopher Grime; Hui-leng Tan
Journal:  Indian J Pediatr       Date:  2015-09-07       Impact factor: 1.967

7.  Circulating Survivin Levels in Obstructive Sleep Apnoea.

Authors:  Laszlo Kunos; Peter Horvath; Adrian Kis; David Laszlo Tarnoki; Adam Domonkos Tarnoki; Zsofia Lazar; Andras Bikov
Journal:  Lung       Date:  2018-05-08       Impact factor: 2.584

8.  T, B, and NKT Cells in Systemic Inflammation in Obstructive Sleep Apnoea.

Authors:  Joanna Domagała-Kulawik; Iwona Osińska; Aleksandra Piechuta; Piotr Bielicki; Tomasz Skirecki
Journal:  Mediators Inflamm       Date:  2015-05-25       Impact factor: 4.711

9.  T regulatory lymphocytes and endothelial function in pediatric obstructive sleep apnea.

Authors:  Hui-Leng Tan; David Gozal; Arash Samiei; Rakesh Bhattacharjee; Yang Wang; Helena Molero Ramirez; Hari P R Bandla; Richa Kulkarni; Leila Kheirandish-Gozal
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

Review 10.  Obstructive sleep apnea in children: a critical update.

Authors:  Hui-Leng Tan; David Gozal; Leila Kheirandish-Gozal
Journal:  Nat Sci Sleep       Date:  2013-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.